EU MDR Compliance: Surviving the Notified Body Capacity Shortage in Europe

This episode delves into the critical capacity crisis among Notified Bodies under the EU's Medical Device Regulation (MDR). We explore how the stringent requirements of the MDR, combined with a reduction in the number of designated Notified Bodies, have created a massive bottleneck for certifying new and legacy medical devices. We discuss the significant risk this poses to manufacturers, who face the possibility of their products being forced off the market as old certificates expire, and examine the European Commission's legislative response to extend the transition deadlines. - What is the EU MDR Notified Body capacity crisis? - Why are there multi-year delays for device certification in Europe? - How did the transition from the MDD to the MDR create a market bottleneck? - What are the crucial deadlines of May and September 2024 for legacy devices? - Could your medical device be forced off the EU market due to expiring certificates? - What steps did the European Commission take to prevent a widespread device shortage? - How does the risk class of your device affect its new transition deadline? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies. We streamline global market access with local expertise and advanced AI, helping you navigate complex challenges like the EU MDR. Our services include developing efficient regulatory strategies, compiling technical dossiers with AI, and acting as your local representative in over 30 markets. We help you meet critical deadlines and maintain market presence. For support with your global expansion, contact us at [email protected], visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.